Personal information

Emails & domains

Verified email domains

Other IDs

Loop profile: 1374545

Keywords

NAFLD, diabetes, cardiometabolic syndrome

Countries

Belgium

Biography

PhD student with research interest in insulin resistance and fatty liver disease in people with diabetes

Activities

Collapse all

Employment (3)

University of Antwerp: Antwerp, BE

2019-08-01 to present | PhD student (Laboratory of Experimental Medicine and Paediatrics)
Employment
Source: Self-asserted source
Jonathan Mertens

Antwerp University Hospital: Antwerp, BE

2019-08-01 to present | Resident/PhD student (Hepatology)
Employment
Source: Self-asserted source
Jonathan Mertens

Ziekenhuisnetwerk Antwerpen Stuivenberg: Antwerp, BE

2018-08-01 to 2019-07-31 | Resident (Internal Medicine)
Employment
Source: Self-asserted source
Jonathan Mertens

Education and qualifications (2)

University of Antwerp: Antwerp, BE

2019-08-01 to present | PhD trajectory (Medicine )
Education
Source: Self-asserted source
Jonathan Mertens

University of Antwerp: Antwerp, Antwerp, BE

2015-09-25 to present | Master of Science (Medicine)
Education
Source: Self-asserted source
Jonathan Mertens

Professional activities (6)

European Society of Endocrinology: Bristol, GB

Service
Source: Self-asserted source
Jonathan Mertens

European Association for the Study of the Liver: Geneve, GE, CH

Membership
Source: Self-asserted source
Jonathan Mertens

European Association for the Study of Diabetes: Dusseldorf, Nordrhein-Westfalen, DE

Service
Source: Self-asserted source
Jonathan Mertens

young Belgian Association for the Study of the Liver : Brussels, BE

2020-08-01 to present | Active member
Membership
Source: Self-asserted source
Jonathan Mertens

European Young Endocrine Scientists (EYES): Antwerp, BE

2019-08-01 to present
Membership
Source: Self-asserted source
Jonathan Mertens

Belgian Endocrine Society (BES): Brussels, VA, BE

2019-08-01 to present
Membership
Source: Self-asserted source
Jonathan Mertens

Works (12)

The 13C Glucose Breath Test Accurately Identifies Insulin Resistance in People With Type 1 Diabetes

The Journal of Clinical Endocrinology & Metabolism
2025-01-21 | Journal article
DOI: 10.1210/clinem/dgae175
Contributors: Jonathan Mertens; Laurence Roosens; Rie Braspenning; Joeri Vandebeeck; Sven Francque; Christophe De Block
Source: check_circle
Crossref

Insulin Resistance and CGM-Derived Parameters in People With Type 1 Diabetes: Are They Associated?

The Journal of Clinical Endocrinology & Metabolism
2024-10-15 | Journal article
DOI: 10.1210/clinem/dgae015
Contributors: Isabel Clinck; Jonathan Mertens; Kristien Wouters; Eveline Dirinck; Christophe De Block
Source: check_circle
Crossref

Metabolic dysfunction-associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes.

Diabetes, obesity & metabolism
2024-06-25 | Journal article
DOI: 10.1111/dom.15723
PMID: 38924290
Contributors: Chloë Aernouts; Beldé SPW; Lambrechts J; Mertens J; Ledeganck KJ; Francque SM; De Block CEM
Source: Self-asserted source
Jonathan Mertens

Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes

JHEP Reports
2023-07 | Journal article
DOI: 10.1016/j.jhepr.2023.100753
Contributors: Jonathan Mertens; Jonas Weyler; Eveline Dirinck; Luisa Vonghia; Wilhelmus J. Kwanten; Laura Mortelmans; Cedric Peleman; Shivani Chotkoe; Maarten Spinhoven; Floris Vanhevel et al.
Source: check_circle
Crossref

An accidental finding of a giant intra-abdominal mass

Acta Chirurgica Belgica
2023-01-02 | Journal article
DOI: 10.1080/00015458.2021.1920668
Contributors: Jonathan Mertens; Ann Driessen; Niels Komen
Source: check_circle
Crossref

Artifactual hypoglycemia in a patient with systemic sclerosis

Acta Clinica Belgica
2022-03-04 | Journal article
DOI: 10.1080/17843286.2020.1837575
Contributors: Jonathan Mertens; Maryam Haddad
Source: check_circle
Crossref

Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy

Frontiers in pharmacology
2021-10-25 | Journal article
PMC: PMC8573337
Source: Self-asserted source
Jonathan Mertens

Estimated glucose disposal rate, non-alcoholic fatty liver disease and micro- and macrovascular complications in type 1 diabetes: Towards a new predictor?

Diabetologia
2021-09 | Conference abstract
DOI: 10.1007/s00125-021-05519-y
Part of ISSN: 0012-186X
ISSN: 1432-0428
Source: Self-asserted source
Jonathan Mertens

Therapeutic approaches for non-alcoholic steatohepatitis

Therapeutic Advances in Endocrinology and Metabolism
2021-09-03 | Journal article
DOI: 10.1177/20420188211034300
Part of ISSN: 2042-0188
Part of ISSN: 2042-0196
Source: Self-asserted source
Jonathan Mertens

NAFLD in type 1 diabetes: overrated or underappreciated?

Therapeutic Advances in Endocrinology and Metabolism
2021-01 | Journal article
DOI: 10.1177/20420188211055557
Contributors: Jonathan Mertens; Luc F. Van Gaal; Sven M. Francque; Christophe De Block
Source: check_circle
Crossref

The role of insulin resistance and NAFLD in the cardiometabolic risk profile of type 1 diabetes

Diabetologia
2020-09 | Conference poster
DOI: 10.1007/s00125-020-05221-5
Part of ISSN: 0012-186X
Part of ISSN: 1432-0428
Source: Self-asserted source
Jonathan Mertens

A case of steroid-responsive, COVID-19 immune reconstitution inflammatory syndrome following the use of granulocyte colony-stimulating factor

Open Forum Infectious Diseases
2020-08-17 | Journal article
DOI: 10.1093/ofid/ofaa326
ISSN: 2328-8957
Source: Self-asserted source
Jonathan Mertens
grade
Preferred source (of 2)‎

Peer review (5 reviews for 5 publications/grants)

Review activity for Acta diabetologica. (1)
Review activity for BMJ open diabetes research and care. (1)
Review activity for Clinical diabetes and endocrinology. (1)
Review activity for Journal of diabetes and metabolic disorders (1)
Review activity for Nutrition & diabetes. (1)
How many people are using ORCID?